Delivery Order SPE2DR25D2205-SPE2DR26F1M46
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets on December 10, 2025, with completion scheduled for January 2, 2026. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product for medical supply purposes. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. This award was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $4,380.39 with an ultimate completion date of December 22, 2025. The contract represents a non-set-aside competitive award, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order for 30 units of Orgovyx 120 mg tablets valued at $1,460.13 by the Defense Logistics Agency (DLA) on November 18, 2025. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by December 10, 2025. The pharmaceutical product will be delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for 30-count units of Orgovyx 120 mg tablets, with a completion date of December 18, 2025. This is a firm fixed-price contract with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 30, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,460.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with a completion deadline of December 10, 2025. This non-set-aside award was issued on November 18, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. This award is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $4,156.56. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of October 9, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1M46Delivery Order
The Defense Logistics Agency awarded a $5,840.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of December 26, 2025. This non-set-aside contract was competitively awarded on December 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger pharmaceutical supply contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support agreement running through December 2026. As a prime vendor for federal medical procurement, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's contract awards demonstrate consistent capability to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 12/3/25 |